Inspiration Healthcare Group plc announced the appointment of Gordon Roy Davis ("Roy") as a Non-Executive Director and successor to Mark Abrahams. Mark has been Chair of the Board since June 2015 following the reverse acquisition of Inditherm plc by Inspiration Healthcare Ltd. Roy will become a Non-Executive Director with effect from 25 January 2024 and Chair from 21 March 2024, when Mark Abrahams will step down from the Board of the Company. On joining the Board, he will be appointed to the Nominations Committee and will succeed Mark Abrahams as Chair of this Committee. Roy brings a wealth of commercial experience in medical devices companies and has a proven track record of successfully scaling companies and delivering substantial value for shareholders.

He has held leadership positions at a number of publicly quoted med tech companies, including CEO of Optos plc, a leading retinal imaging device manufacturer, from 2008 to 2016 until its sale to Nikon for £259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus Group plc, a leader in minimally invasive surgery and visualisation, until its acquisition by Olympus Corporation in 2008 for $1.9 billion. He is currently Non-Executive Chair at LungLife AI plc, Foster and Freeman (the trading name of the Galton group of companies) and Rair Health Ltd. and was until recently, Non-Executive Chair at Medica Group plc until its acquisition by IK Partners for £269 million earlier this year.